Trial intelligence / Profile preview

Norepinephrine ED90 for Post-Spinal Hypotension in C-Section

NCT06151509Unknown

Sponsor
General Hospital of Ningxia Medical University
Start
Jan 2025
Primary completion
Mar 2025
Modality
Small Molecules
01

Overview

Randomised trial of norepinephrine in hypotension (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Effective Dose 50% and Effective Dose 90%. Status: unknown.

02

Drugs

norepinephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT06151509.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06151509.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call